{
  "trial_id": "NCT01575249",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "mild to moderate AS (Table 1)",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "progression factors are summed-up below",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "female sex, PV and BNP at baseline were correlated with AS progression",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "increased progression was present in those with resting mean gradient (MG) >35 mmHg",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "strain gradually decreased as severity of AS increases and that global longitudinal strain (GLS)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "longitudinal, radial and circumferential strain and strain rate (SR) deteriorate with aortic valve disease progression",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Progression rates begin from 0.15\u00b10.01 m/s/y in population without cardiovascular risk factors",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "High progressors are those that have at least one abnormal parameter of the followings: echocardiography parameters",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "clinical predictors: CAD, age (>80 years), diabetes, metabolic syndrome (MS)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "biological parameters: parathyroid hormone (PTH) level, BNP at baseline, high lipoprotein (a) and low density lipoprotein (LDL) cholesterol levels",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "No influence on AS progression were treatment with simvastatin and ezetimibe",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Slower progression was observed after osteoporosis and bisphosphonate treatment",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "positive stress test (symptoms including dyspnoea, angina, syncope, ECG pathological changes, WMA)",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "heart failure",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "LVEF < 55%",
      "label": "triggers",
      "evidence": "none"
    }
  ],
  "notes": "Patient has a history of CAD, CHF, obesity hypoventilation syndrome, obstructive sleep apnea, DM2, ventricular tachycardia, hypothyroidism, schizophrenia, COPD, and Pneumonia. Patient is on BiPap at night and has been compliant with medication.",
  "_meta": {
    "topic_id": "14",
    "trial_id": "NCT01575249",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}